A new Research Group at the IRB led by Dr. Samuel Nobs
Samuel Philip Nobs, PhD, will join the Institute for Research in Biomedicine (IRB) as Group Leader in August 2025, to study the interplay between microbiome and lung immune system. His research program will further strengthen the biomedical cluster that is developing at the Bellinzona Institutes of Science (Bios+). Bellinzona, July 31, 2025 – The Foundation […]
Trogocytosis: A New Paradigm for Immune Cell Interactions and Receptor Sharing
Dr. Manuel Albanese National Institute of Molecular Genetics (INGM), Milan, Italy Friday, 04 July 2025 at 02 pm Bios+ Seminar Room
Type 2 Cytokines: a story of macrophages, matrix & metazoan parasites
Prof. Judith Allen University of Manchester, UK. Tuesday, 24 June 2025 at 12 pm Bios+ Seminar Room
Premio San Salvatore 2024 al professor Petr Cejka e alla professoressa Laurence Zitvogel per i loro contributi alla ricerca oncologica
Bellinzona – 2 giugno 2025 – Il professor Petr Cejka e la professoressa Laurence Zitvogel sono i due illustri accademici insigniti del Premio 2024 della Fondazione San Salvatore di Lugano, fondata nel 1979 da Carlo Pernsch, un riconoscimento che viene assegnato a figure di spicco impegnate nella ricerca scientifica contro il cancro. Ciascun premiato ha […]
San Salvatore Prize 2024 to Professor Petr Cejka and to Professor Laurence Zitvogel for their contributions to oncological research
Bellinzona – June 02 2025 – Professor Petr Cejka and Professor Laurence Zitvogel are the two distinguished academics to receive the 2024 Prize from the San Salvatore Foundation in Lugano, founded in 1979 by Carlo Pernsch – an award given to outstanding figures engaged in scientific research against cancer. Each laureate received 50,000 Swiss francs, […]
Antibody Diversity: A Symphony of Protection and Pathogenesis
Prof. Qiao Wang Shanghai Medical College, Fudan University Monday, 2 June 2025 at 4 pm Bios+ Seminar Room Contact: Prof. Davide Robbiani This event is supported by the IRB-Rockefeller University partnership for infectious disease research.
Pharmacologic Rescue of Mutant GCase Folding enhances Lysosomal Function in Gaucher and Related Disorders
A paper published in the International Journal of Molecular Sciences by the Prof. Molinari Laboratory reports on pharmacologic intervention to promote folding of variants of the lysosomal protein glucosylceramidase beta 1 (GCase) linked to Gaucher disease (GD), Parkinson’s disease (PD), and Dementia with Lewy Bodies. Bellinzona – May 16 2025 – Lysosomes maintain cell’s and […]
New IRB Group Leader
An international call for applications was held during 2024 to select a new Group Leader. A shortlist of candidates, from top universities in Europe and the United States, were invited to Bellinzona where they presented their studies results and future research agenda. The choice fell on Dr. Samuel Nobs, who after receiving his doctorate from […]
EXO1 promotes the meiotic MLH1-MLH3 endonuclease through conserved interactions with MLH1, MSH4 and DNA
A paper published in the journal “Nature Communications” by the Cejka laboratory shows how EXO1, a nuclease known for its role in DNA end resection in homologous recombination and in DNA mismatch repair, has a nuclease-independent role to promote the nuclease activity of MLH1-MLH3 complex. Bellinzona – May 08 2025 – During meiosis – a […]
Expansion of Scientific Collaboration Agreement between IRB and Humanitas University
Since 2019 IRB and Humanitas University, located in Pieve Emanuele (Milan), have had agreements to facilitate joint scientific projects and student exchange. In 2024, this agreement was renewed and extended to include the Humanitas Hospital, an institution focused on excellence in clinical care and research. In particular, in future years it is intended to intensify […]
